NASDAQ:VANI
Vivani Medical, Inc.
Vivani Medical, Inc.'s revenue was $0 in fiscal 2025. Free cash flow was −$25.5M, and the diluted share count rose 13.5%.Summary generated from Vivani Medical, Inc.'s SEC filings. Latest annual report filed Mar 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$0
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−159.6%
Debt / equityn/a
Free cash flow−$25.5M
FCF marginn/a
Share count change+13.5%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | 0 | 0 |
| Operating income | −13 | −21 | −27 | −25 | −28 |
| Net income | −13 | −14 | −26 | −23 | −27 |
| Free cash flow | −12 | −19 | −25 | −21 | −25 |
Recent filings
- 8-KRegulation FD disclosure
Sep 16, 2026 - 8-KRegulation FD disclosure
Aug 17, 2026 - 8-KResults of operations and financial condition
Aug 13, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026 - 8-KRegulation FD disclosure
Aug 6, 2026 - 4Insider transaction report
Jul 30, 2026 - 4Insider transaction report
Jul 30, 2026 - 8-KRegulation FD disclosure
Jul 16, 2026